Super disappointed! It will be interesting to see what happens tomorrow morning. On one hand you have Gerald doing anything but "announcing top-line results of its expanded LP-002 study" of Lympro, and then you have the $300 million dollar forecast for MSPrecise.....efff
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links